GH

Guardant Health, Inc.

Guardant Health, Inc. (GH) has 37 SEC Form 4 filings (119 transaction rows) in the rolling window, disclosed by 10 distinct insiders. Most recent filing: Jul 16, 2026.

The most active filer is Co-Chief Executive Officer Talasaz AmirAli with 4 filings. Insiders have net sold $76.3M over the trailing 6 months.

  • Industry:Medical - Diagnostics & Research
  • CEO:Helmy Eltoukhy
  • Employees:1,999
  • HQ:Palo Alto, CA, US
  • IPO:2018-10-04

Insider Buying

$78K

reported purchases (SEC code P)

Insider Selling

$82.3M

reported sales (SEC code S)

Unique Insiders

10

in the rolling window

Market Cap

$21.6B

latest known value

Source
Sale$19KJul 16SEC ↗
Kalia KumudFirst filing
Sale$79KJun 30SEC ↗
Kalia KumudFirst filing
Purchase$78KJun 30SEC ↗
Kalia KumudFirst filing
Sale$79KJun 30SEC ↗
Sale$17.6MJun 30SEC ↗
Sale$21.7MJun 30SEC ↗
POTTER MYRTLE SFirst filing
Sale$204KJun 23SEC ↗
Tariq MusaFirst filing
Sale$256KJun 23SEC ↗
Krognes Steve E.First filing
Sale$1.2MJun 5SEC ↗
Sale$1.3MMay 28SEC ↗
Freeman ChrisFirst filing
Sale$2.9MMay 26SEC ↗
Saia John G.First filing
Sale$2.1MMay 22SEC ↗
Sale$23.1MMay 22SEC ↗
CLARK IAN TFirst filing
Sale$735KMay 22SEC ↗
Sale$134KMay 22SEC ↗
Talasaz AmirAliFirst filing
Sale$5.0MMay 13SEC ↗
Monroe Terilyn J.First filing
Sale$5.8MDec 3SEC ↗

Related companies

Guardant Health, Inc. is in the Healthcare sector.